HARRISON F. FLIPPIN, M.D.
The incidence of undulant fever in the United States is steadily on the increase. The United States Public Health Service statistics1 for 1927 show only 112 cases as compared to 2008 reported in 1935. With this increase in the prevalence of the disease we find numerous reports2 dealing with therapy. It is not the purpose of this paper to attempt to evaluate the various forms of treatment but to report five cases of the disease which were effectively treated with a specific polyvalent serum.2
The antimelitensis serum used in the treatment of these cases was a sterile polyvalent antiserum of
FLIPPIN HF. TREATMENT OF UNDULANT FEVER; A REPORT OF FIVE CASES TREATED WITH A SPECIFIC POLYVALENT SERUM1. Ann Intern Med. ;12:232–235. doi: 10.7326/0003-4819-12-2-232
Download citation file:
Published: Ann Intern Med. 1938;12(2):232-235.
Hematology/Oncology, Hospital Medicine.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use